Health
India to review COVID-19 vaccines after blood clot warning – bdnews24.com
A government panel of experts is investigating for any domestic cases of blood clotting, even mild ones, as a side effect of the two COVID-19 vaccines being administered…
India is currently administering AstraZenecas COVID-19 vaccine, which is manufactured by the Serum Institute and branded Covishield, and a shot developed by Bharat Biotech called COVAXIN.
The review comes after Europes drug regulator said on Wednesday it found a possible link between AstraZenecas vaccine and rare blood clotting issues in adults who had received the shot, although it added the vaccines advantages still outweighed the risks.
India is banking on vaccinations to help contain a record…
-
Business19 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
Noosa News18 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
General13 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News15 hours agoTips to improve engagement – Proctor